Industry News
Adult Stem Cells Isolated From Human Intestinal Tissue For The First Time
Apr 08, 2013
For the first time, researchers at the University of North Carolina at Chapel Hill have isolated adult stem cells from human intestinal tissue. The accomplishment provides a much-needed resource for scientists eager to uncover the true mechanisms of human stem cell biology... Read More
Scientists Describe The Mechanics Of Oncogene-Induced Senescence
Apr 08, 2013
Researchers from The Wistar Institute explain a new molecular mechanism behind the phenomenon of oncogene-induced senescence. By depriving the cell of the ability to make new nucleotides - the building blocks of DNA molecules - cells can suppress cancer development by forcing a damaged cell into a senescent state, where the cell remains alive yet cannot reproduce... Read More
Potential Drug Target For Infectious Disease Revealed By Scissor-Like Enzyme
Apr 08, 2013
UT Southwestern Medical Center researchers report that a pathogen annually blamed for an estimated 90 million cases of food-borne illness defeats a host's immune response by using a fat-snipping enzyme to cut off cellular communication... Read More
New Frontiers In Breast Cancer Screening
Apr 08, 2013
Researchers at Moffitt Cancer Center predict that advancements in breast cancer screening will need a personalized touch because mammography is not a "one strategy fits all" technology. Their review "Beyond Mammography: New Frontiers in Breast Cancer Screening" appears in The American Journal of Medicine... Read More
Despite Menopause-Like Side Effects, Continuous Hormone Treatment For Prostate Cancer Is Superior To Intermittent Therapy
Apr 07, 2013
A study published in the New England Journal of Medicine recommends a dramatic shift in the way doctors treat metastatic prostate cancer. "These results have changed the way I treat patients," said Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio and senior author on the international study... Read More
Chemotherapy Found To Work In An Unexpected Way
Apr 07, 2013
It's generally thought that anticancer chemotherapies work like antibiotics do, by directly killing off what's harmful. But new research published online in the Cell Press journal Immunity shows that effective chemotherapies actually work by mobilizing the body's own immune cells to fight cancer... Read More
Abnormal Copy Numbers Characterises Prostate Cancer
Apr 06, 2013
Non-invasive 'liquid biopsies' can find metastatic or recurrent prostate cancer, in a low cost assay suitable for most healthcare systems, finds research published in BioMed Central's open access journal Genome Medicine. Genomic signatures of prostate cancer, isolated from plasma DNA, display abnormal copy numbers of specific areas of chromosomes... Read More
Genotype-Specific Targeted Therapies For Lung Cancer
Apr 06, 2013
Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells - a specific genetic weakness that can be exploited for new therapies. Although researchers have long known that mutant versions of the KRAS gene drive tumor formation and are key to cell survival in non-small cell lung cancer, the blocking of activated KRAS has proven difficult... Read More
IDH1 And IDH2 Mutant Inhibitors Reverse Differentiation Blocks In Patient-Derived Tumor Samples
Apr 06, 2013
Agios Pharmaceuticals, Inc... Read More
One Specific MicroRNA Appears To Promote Tumor Growth And Cancer Spread
Apr 05, 2013
Researchers at Moffitt Cancer Center have determined that the overexpression of microRNA-155 (miR-155), a short, single strand of ribonucleic acid encoded by the miR-155 host gene, promotes the growth of blood vessels in tumors, tumor inflammation, and metastasis. As a therapeutic target, miR-155 could potentially provide a new avenue of treatment when targeted with drugs to suppress its activity... Read More
Previous Page Next Page